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Abstract Five wastewater treatment plant effluents were
analyzed for known endocrine disrupters and estrogenic-
ity. Estrogenicity was determined by using the yeast es-
trogen screen (YES) and by measuring the blood plasma
vitellogenin (VTG) concentrations in exposed male rain-
bow trout (Oncorhynchus mykiss). While all wastewater
treatment plant effluents contained measurable concentra-
tions of estrogens and gave a positive response with the
YES, only at two sites did the male fish have significantly
increased VTG blood plasma concentrations after the ex-
posure, compared to pre-exposure concentrations. Estrone
(E1) concentrations ranged up to 51 ng L–1, estradiol (E2)
up to 6 ng L–1, and ethinylestradiol (EE2) up to 2 ng L–1 in
the 90 samples analyzed. Alkylphenols, alkylphenolmo-
noethoxylates and alkylphenoldiethoxylates, even though
found at µg L–1 concentrations in effluents from waste-
water treatment plants with a significant industrial con-
tent, did not contribute much to the overall estrogenicity
of the samples taken due to their low relative potency. Ex-
pected estrogenicities were calculated from the chemical
data for each sample by using the principle of concentra-
tion additivity and relative potencies of the various chem-
icals as determined with the yeast estrogen screen. Mea-
sured and calculated estradiol equivalents gave the same
order of magnitude and correlated rather well (R2=0.6).
Keywords Endocrine disruption · Fish exposure · Yeast
estrogen screen · Vitellogenin · Steroid hormones ·
Nonylphenol ethoxylates
Introduction
Endocrine-disrupting chemicals (EDCs) in the aquatic en-
vironment have become an increasingly important issue
for scientists and regulatory bodies. As early as 1970, Tabak
and Bunch were investigating the risk posed by natural
urinary and especially synthetic ovulation-inhibiting hor-
mones [1, 2], work that was later taken up by other groups
[3, 4, 5, 6, 7]. The impact of the steroid hormones on the
environment is highlighted by the fact that concentrations
as low as 0.1 ng L–1 of ethinylestradiol [8] and 1–10 ng L-1
of estradiol [9] induce vitellogenesis in male rainbow trout.
This high potency at low concentrations necessitates un-
derstanding of the fate and effects of these compounds in
the aquatic environment. In the early 1990s various man-
made chemicals were also identified as disrupters of the
endocrine system [10, 11] and their fate and behavior be-
came a major research topic [12]. Since then, accumulat-
ing evidence suggests that these chemicals may also affect
the health and possibly the fertility of humans and wildlife
[13, 14, 15].
To predict environmental concentrations of steroid hor-
mones in river waters, Johnson and co-workers used an ex-
posure assessment model [16, 17, 18]. They expected
concentrations below 0.4 ng L–1 for estradiol and estrone,
and 10 times less for ethinylestradiol. This expectation
agrees well with values in the ng L–1 range reported by
various groups for wastewater treatment plant effluents
when the dilution of the effluent in the receiving rivers is
taken into account [5, 7, 19, 20, 21, 22, 23, 24].
The very low environmental concentrations expected
for natural and synthetic steroid hormones require sophis-
ticated analytical techniques for their measurement and
assessment of their effect on aquatic organisms. Biologi-
cal tools are needed to measure effects, which are inte-
grated responses to all estrogenic chemicals present, in-
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cluding those that might be missed by chemical analysis.
Hence, in vitro testing of environmental samples and chem-
icals has become an important complementary technique
to classical chemical analysis [25, 26, 27, 28]. It allows
targeting known and unknown chemicals and mixtures of
chemicals that cause specific effects at the cellular or mo-
lecular level, and it can be used for high-throughput
screening. By using the yeast estrogen screen (YES) as an
in vitro test system, effects can be measured as a result of
additivity in a mixture of EDCs, even if the concentration
of individual EDCs is below the no-effect concentration
[29]. However, in vitro tests represent an artificial system,
and their responses should be validated with in vivo ex-
periments [30]. For this reason, the induction of vitello-
genin (VTG) in juvenile or male fish in vivo has become
an accepted biomarker of exposure to estrogenic compounds
[8, 31].
In the work presented here we have applied a combina-
tion of chemical analysis and various bioanalytical tools
(in vitro and in vivo) for assessing estrogenicity in waste-
water treatment plant (WWTP) effluents and their receiv-
ing waters. We have used this approach to correlate chem-
ical data with biological effects and could show that: i) nat-
ural and synthetic steroid hormones are the major contrib-
utors to estrogenicity in WWTP effluents, ii) the mea-
sured (YES) and calculated (based on chemical analysis)
estrogenicity correlated well, and iii) no false negative re-
sults were obtained in vitro, since the VTG induction in
exposed male fish was matched by the response of the
YES assay.
Materials and methods
Chemicals
The standards β-estradiol-17-acetate, 17-α-ethinylestradiol, 17-β-
estradiol, estriol, estrone, and 2,4,6-trimethylphenol were from
Sigma-Aldrich (Buchs, Switzerland). E2 and EE2 used in the YES
were from Fluka (Buchs, Switzerland), 1,4-dithioerythritol (DTE,
>99%) was from VWR Int. AG (Dietikon, Switzerland), 1-(tri-
methylsilyl)imidazole (T(M)SIM, >98%) and N-methyl-N-trimeth-
ylsilyltrifluoroacetamide (MSTFA, ≈99%) from Fluka (Buchs,
Switzerland). All solvents were puriss p.a., or HPLC-grade.
Sample collection for chemical and in vitro analysis
Three-day composite water samples were collected by using cooled
(5°C) mobile sampling devices (ISCO Model 6700 Standard, IG
Instrumenten-Gesellschaft, Zurich, Switzerland) fitted with ace-
tone-rinsed 4-L glass or aluminum (France1 and France2) bottles.
Sampling locations were WWTP effluents, the river upstream of
the point of discharge, and Lake Lucerne at Kastanienbaum. To
prevent sample degradation, samples were stabilized by adding 
10 mL 36% formaldehyde solution (NPnEO analysis, n=0–2), or
10 mL methanol (steroid analysis and YES) per liter. The samples
were stored at 4°C and processed within 48 h (steroid analysis and
YES) or 14 d (NPnEO analysis, n=0–2), or frozen at –18°C if en-
richment was delayed. An internal standard (25 ng L–1) was added
before the enrichment for steroid (E2-acetate) and NPnEO chemi-
cal analysis (2,4,6-trimethylphenol).
Enrichment for steroid analysis and in vitro testing
Solid-phase extraction (SPE) was performed according to the
method reported by Ternes et al. [22]. Briefly, 1 L of sample was
vacuum filtered through a glass fiber filter (GF/F, 90 mm, What-
man International Ltd, Kent, UK), and the pH of the filtrate was
adjusted to 3 with 16% aqueous HCl. The enrichment step was car-
ried out by using 3-mL self-packed polypropylene SPE tubes (Su-
pelco, Buchs, Switzerland) containing a mixed solid phase
(LiChrolut RP18 and LiChrolutEN; VWR Int. AG, Dietikon,
Switzerland). After drying of the solid phase, analytes were eluted
successively with 4×1 mL acetone. For steroid analysis, the solvent
was reduced to 200 µL under a gentle stream of N2. The extract
was then further cleaned on a 6-mL SPE column containing 1 g of
silica gel (Sigma-Aldrich, Buchs, Switzerland), deactivated with
1.5% H2O (w/w). Conditioning and elution were done with hex-
ane/acetone 6:4 (v/v). The eluate was subsequently derivatized for
GC/MS analysis (see below). For the in vitro testing, the acetone
was evaporated completely and the residues were then taken up in
500 µL of absolute ethanol. Blank samples were prepared from
Dubendorf groundwater (chemical analysis) or deionized water
(YES) and extracted and treated in the same way as the environ-
mental samples.
GC/MS analysis of steroid hormones
The solid-phase extracts were derivatized according to the method
reported by Ternes et al. [22] by using MSTFA/TSIM/DTE,
1,000:2:2 (v:v:w) and separated on a GC Fisons 8000 equipped
with a PTV injector OPTIC 2 (ATAS, The Netherlands). We in-
jected 10-µL volumes split-less onto a plug of deactivated fused
silica (Restek, BGB Analytik AG, Anwil, Switzerland). The car-
rier gas was He (Carbagas, Zurich, Switzerland). The column was
a XTI-5, 30-m, 0.25-mm ID, 0.25-µm film thickness (Restek) at-
tached to a 2-m pre-column (Siltek, 0.53-mm ID, Restek). GC tem-
perature program: 110°C (4 min), 17°C to 238°C, 1.7°C to 260°C,
10°C to 300°C, 300°C isothermal (7 min).
High-resolution mass spectrometry (resolution 8,000 at 5%
valley) with positive electron ionization on an Autospec-Q (Mi-
cromass, Manchester, UK) was used to detect steroid hormones.
The transfer lines were set to 300°C, and the source temperature to
280°C. Optimized EI+ conditions for steroid hormones resulted in
an electron energy of 54 eV and a trap current of 700 µA. The de-
tector was set to 375 V. Low-boiling PFK (Fluka, Buchs, Switzer-
land) was used for calibration and lock masses. Single-ion moni-
toring was used during data acquisition.
Recoveries determined from two independent datasets (January
2000/November 2001) for groundwater samples spiked with 30 ng
L–1 of the standard steroid mixture prior to or after the enrichment,
were 114/106% for E1, 117/100% for E2, 119/100% for EE2, and
40/25% for estriol E3 (n=8). For effluent samples, recoveries were
160/136% for E1, 122/80% for E2, 141/104% for EE2, and 166/
4% for E3 (n=8). The corresponding standard uncertainties for
groundwater samples were 15% for E1, 22% for E2, 25% for EE2,
689
Table 1 Relative estrogenic potencies (REP) determined with the yeast estrogen screen [33]
E1 E2 E3 EE2 NP
Relative estrogenic potencies 0.38 1 2.4×10–3 1.19 2.50×10–5
Lower and upper 95% confidence limits 0.36–0.40 0.97–1.04 2.3×10–3–2.5×10–3 1.15–1.24 2.4×10–5–2.7×10–5
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and 173% for estriol E3 (n=8). For effluent samples, they were
60% for E1, 23% for E2, 42% for EE2, and 116% for E3 (n=8).
The highly varying recoveries and corresponding high uncertain-
ties for E3 can be explained by the relatively high polarity of the
compound, which means that recoveries are affected strongly by
the activity of the silica column. Only slight changes in the activ-
ity can lead to large losses. Limits of quantitation at signal-to-noise
ratios of 10:1 were strongly matrix-dependent and had to be deter-
mined separately for each experiment.
Enrichment and analysis of alkylphenolethoxylates
The analytical procedure for determining nonylphenol (NP),
nonylphenolmonoethoxylate (NP1EO), and nonylphenoldiethoxy-
late (NP2EO) in environmental samples is based on the work pub-
lished by Ahel et al. [32]. We enriched 100-mL samples by liq-
uid–liquid extraction with 3×2 mL hexane. The hexane phase was
dried with anhydrous sodium sulfate, and the volume reduced to
500 µL under a gentle stream of N2. The analysis was performed
by using normal-phase HPLC on an HP1090 Series II liquid chro-
matograph (HPLC) equipped with a photodiode array detector (HP
1090) and a programmable fluorescence detector (HP 1046) from
Agilent Technologies AG (Basel, Switzerland).
In vitro analysis (YES)
The yeast cells were stably transfected with the human estrogen re-
ceptor gene and an expression plasmid containing estrogen-re-
sponsive elements (ERE) which control the β-galactosidase-en-
coding reporter gene lacZ. The translated β-galactosidase is se-
creted into the medium, and its activity is determined by measur-
ing the absorbance at 540 nm. Culture and exposure of the yeast
cells were performed as described by Routledge and Sumpter [25].
Inhibition of yeast cell growth was regarded as an acute toxic ef-
fect of a tested sample or compound; this was observed as a reduc-
tion of absorbance at 620 nm, compared to reference wells. Dilu-
tion series of E1, E2, EE2, E3, NP, and the WWTP effluent ex-
tracts were prepared in ethanol. Ten µL of each dilution of the
standard compounds and 20 µL of the dilutions of the effluent
samples were added to 96-well microtiter plates. The ethanol was
evaporated and the yeast cells were added in growth medium. At
least four replicate wells per dilution were used.
Calculated and measured estradiol equivalents (E2-EQ)
Estrogenic activity (expressed as estradiol equivalency E2-EQ calc
in ng L–1) calculated from steroid and nonylphenolethoxylate
chemical data was based on potencies relative to E2 as determined
with the YES (Table 1). Associated uncertainties were calculated
based on the uncertainties of the chemical determination and rela-
tive potencies by following the rules of error propagation [33].
Estradiol equivalency of samples measured with the YES was
determined by interpolation from E2 standard curves [33]. Stan-
dard deviations of replicate measurements with the YES are shown.
Fish exposure experiments
Five exposure experiments were performed with fish at three Swiss
and two French WWTPs. For reasons of confidentiality, the French
WWTPs will be called France1 and France2. The WWTPs chosen
for this study received either mostly urban (Glatt, France1) or a
mixture of urban and industrial influent (Rontal, Surental, France2;
see Table 2). The five plants had activated sludge treatment and
were operating under nitrifying conditions. The actual population
in the catchment area ranged from 11,000 to 88,000 people.
Before the start of the exposure, mostly male adult rainbow
trout (Oncorhynchus mykiss) purchased from a hatchery (Teddy
Waser, Andelfingen, Switzerland) were allowed to acclimate in the
laboratory for two weeks. During this time they were fed ad libi-
tum with commercially available pellets (Hokovit, Silver Cup,
Hofmann AG, Butzberg, Switzerland). The fish were anesthetized
in a solution containing MS222 (100 mg L–1 3-aminobenzoic acid
ethyl ester, Redmont, USA) and individually marked with num-
bered jaw tags [34] for future identification. Body length and
weight were measured and blood samples were collected by using
lithium-heparinized monovettes (Sarstedt, Numbrecht, Germany).
After acclimation, the fish were exposed to 100% WWTP efflu-
ent, or 50% WWTP effluent mixed with upstream river water
(Surental, France1, and France2 only), or upstream river water (0%
WWTP effluent), or Lake Lucerne water (laboratory control) in
black 400-L polyethylene (HD) tanks. The accuracy of the 50%
mixing was verified by comparing the expected with the actual
measured temperature (R2 values for the linear regressions were
0.95, 0.99, and 0.85 for Surental, France1, and 2, respectively).
During each experiment the fish were kept in the dark without feed-
ing. Each treatment was done in three replicates using three tanks
with an average of 10 fish. When an experiment ended, the fish
were killed with a blow to the head and processed immediately.
Length and total weight were measured, blood samples collected,
and the sex determined. The fish were then dissected and the liver
and gonads weighed. During the exposures the following standard
parameters were measured: temperature, oxygen concentration, pH,
conductivity, ammonium, nitrate, nitrite, and phosphate.
Determination of VTG blood plasma concentrations
Blood was collected from the caudal vein of each fish in every
treatment. After centrifugation at 2,000 g and 4°C, blood serum
was collected in Eppendorf tubes, snap-frozen in liquid nitrogen
and stored at –80°C until further analysis. VTG levels were ana-
lyzed in the blood samples from the fish exposed at all five sites by
using a new homologous, polyclonal anti-rainbow trout vitel-
logenin antibody in a newly established sandwich ELISA protocol.
For the production of polyclonal anti-VTG antibody, New Zealand
white rabbits (M. Moerter, Uerschhausen, Switzerland) were im-
munized by subcutaneous injections of 30 µg rainbow trout VTG
(Biosense, Norway) in complete Freunds adjuvant (day 0) fol-
lowed by 2 booster injections of 20 µg VTG each in incomplete
Freunds adjuvant on days 28 and 56 (both from Sigma-Aldrich,
Buchs, Switzerland). Test bleedings were done on days 42 and 70
by puncture of the arteria auricularis. After 12 weeks, the animals
were terminally bled by heart puncture under narcosis.
ELISA protocol
Plates were coated with 3,000×diluted primary monoclonal anti-
bodies BN-5 (Biosense, Norway) in blocking buffer (PBS, 0.05%
Tween 20, 2% milk powder) and washed with washing buffer
(PBS, 0.05% Tween 20). The plates were subsequently incubated
with 100 µL of 750-fold-diluted rainbow trout plasma for 2 h,
washed with washing buffer, and further incubated overnight at
4°C with polyclonal anti-VTG antibodies, then diluted 1:7,500 in
blocking buffer. After rinsing with washing buffer, the plates were
incubated with goat anti-rabbit horseradish peroxidase (diluted
1:3,000 in blocking buffer) for 2 h at room temperature and rinsed
with washing buffer. Horseradish peroxidase activity was quanti-
fied using chemiluminescence substrate according to the manufac-
turer’s instructions (Promega, Mannheim, Germany).
Results and discussion
Chemical analysis
Chemical data for steroid hormones and nonylphenolethoxy-
lates acquired during all the exposure experiments, to-
gether with the estradiol equivalents (E2-EQ) determined
with YES, are shown in Table 3. Maximal values obtained
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in the 90 samples analyzed were 50.5 ng L–1 estrone (Rontal
100% effluent), 9.8 ng L–1 estradiol (France2 100% effluent),
17.5 ng L–1 estriol (Rontal 100% effluent), and 2.8 ng L–1
ethinylestradiol (Rontal 100% effluent) and a measured
estrogenicity of 53.0 ng L–1 (YES E2-EQ, Rontal 100% ef-
fluent). The 50.5 ng L–1 maximal estrone concentration de-
termined in the Rontal effluent is well matched by the mea-
sured estrogenicity as determined with the YES (53.0 ng L–1)
and two other in vitro tests ([33], data not shown), but this
value clearly deviates from the rest, which did not exceed
5.5 ng L–1 for measured estrogenicity (YES E2-EQ; Glatt
100% effluent). Since this was a singular event, it was not
included in the data set used for the correlation analysis,
for reasons of clarity.
The E2 values determined during the Surental exposure
(100% effluent: 0.8–3.2 ng L–1, 50% effluent: 1.0–3.8 ng L–1,
and river: 0.8–3.8 ng L–1) were not considered for further
analysis, because except for the Lake Lucerne concentra-
tions (<limit of quantitation (LOQ) –1.1 ng L–1), all were
similar, indicating a contamination of unknown origin. On
the other hand, E1 concentrations (100% effluent: 2.0–
5.9 ng L–1, 50% effluent: 1.6–3.7 ng L–1, and river: <LOQ)
and the E2-EQ obtained with the YES (100% effluent:
0.5–2.2 ng L–1, 50% effluent: 0.2–1.6 ng L–1, and river:
<LOQ) decreased, clearly reflecting the expected dilution.
LOQs at the ng L–1 level are influenced greatly by the
matrix of the sample. Hence, LOQs must be determined
independently for each environmental sample. In 100%
WWTP effluent LOQs ranged from 0.7 to 1.0 ng L–1 for
E1, 0.5 to 0.9 ng L–1 for E2, 1.0 to 1.5 ng L–1 for E3, 0.7 to
1.0 ng L–1 for EE2. LOQs in Lake Lucerne water were 
0.1 ng L–1 for E1, 0.3 ng L–1 for E2, 0.3 ng L–1 for E3, and
0.2 ng L–1 for EE2. The LOQs for the alkylphenols were
0.09 µg L–1 for NP, and 0.08 µg L–1 for NP1/2EO in all
matrices.
In light of the ongoing discussion about effects of mix-
tures of causative agents at individual concentrations be-
low effect levels [29], there is clearly a need to further
lower the LOQs for the determination of steroidal estro-
gens. Affinity techniques and the use of immunosorbents
have been shown to be promising selective enrichment or
clean-up tools [24, 35, 36].
Maximal concentrations in all 90 samples analyzed were
up to 1.74 µg L–1 for NP, up to 2.58 µg L–1 for NP1EO, and
up to 3.97 µg L–1 for NP2EO.
Effluent concentrations similar to those reported here
were found throughout Europe and correspond well to
predictions made by Johnson et al. [17, 37]. Generally, the
highest concentrations are found for E1, followed by E3
and E2. These relative concentrations agree with the rela-
tive amounts found in the urine of pre-menopausal
women. Post-menopausal women excrete more E2 than
E3, but the absolute hormone concentrations are lower
[38].
However, chemical data on steroidal estrogens have to
be considered with the corresponding uncertainties in
mind. Standard uncertainties for effluent samples ranged
between 23% for E2 and 116% for E3. Even if this seems
rather high, it clearly reflects the problems encountered in
ultra-trace analysis in complex sample matrices. Albert
and Horwitz analyzed almost 10,000 intercalibration exer-
cises and derived the following relationship between the
relative standard deviation (RSD; %) and sample concen-
tration (c; mass ratio in g g–1): RSD=2^[1–0.5logc] [39].
Thus, at a concentration of 1 ng L-1, the expected relative
standard deviation is 130%, without accounting for the
physical and chemical properties of the analytes. Estriol,
for example, is the most polar of the steroid metabolites
investigated and for this reason recoveries for E3 depend
strongly on the activity of the silica used in the clean-up
step. Furthermore, E2-acetate proposed by Ternes et al.
[22] is not the ideal internal standard for this polar com-
pound, but since estrogenic activity was also measured
with the YES, we preferred not to use deuterated stan-
dards. This explains the large uncertainty associated with
the chemical data for E3, which however still is well
within the values predicted by Albert and Horwitz [39].
Since the relative estrogenic potency and the measured
concentrations are relatively low (Tables 1 and 3), E3 does
not greatly affect the total calculated estrogenicity.
Calculated estrogenicity versus estrogenicity 
measured with the YES
The relative potencies determined with the yeast estrogen
screen cover a range of five orders of magnitude, with the
natural and synthetic steroid hormones being the most po-
tent (Table 1). The relative estrogenic potency of E3 is
comparable with previously published results using a yeast-
based estrogenic assay [40], but is much lower when com-
pared to cases in which binding affinities with the ER
have been determined [41, 42]. The estrogenic activity is
calculated based on the concept of concentration additivity,
which applies since all investigated EDCs target the same
receptor [29, 43, 44]. The contribution of nonylphenol-
ethoxylates to the total estrogenicity of the effluents mea-
sured is only minor. For instance, even the highest NP con-
centration measured (1,740 ng L–1, France2), corresponds
to an estrogenicity of 0.04 ng L–1 E2, which only accounts
for 0.8% of the total estrogenic activity of 4.9 ng L–1 mea-
sured in this sample with the YES. Similarly insignificant
contributions are obtained for NP1EO and NP2EO.
Data acquired during the five exposure experiments
(with the exception of the Surental dilution and the singu-
lar event in Rontal mentioned above) has been used to
analyze the correlation between measured estrogenicity
(YES) and calculated E2 equivalents. Figure 1 lists
E2-EQs calculated (E2-EQ calc) based on the chemical
data as a function of the measured estrogenicity (YES) for
each sample. The error bars reflect the standard error of
the measured estrogenicity (replicate measurements) and
E2-EQ calculated for each sample. The error bars for the
calculated E2-EQs incorporate the uncertainties of the
chemical measurements (up to 116% for E3) and the rela-
tive estrogenic potencies. Since a traditional least-squares
estimation would be biased due to these uncertainties, we
calculated the geometric mean functional relationship [45].
A positive correlation (R2=0.60) was observed between these
two parameters, indicating that the natural and synthetic
steroid hormones represent the major contributors to the
measured estrogenicity. However, alkylphenols and their
ethoxylates and other xenoestrogens might have to be
monitored in special cases for instance when the WWTP
influent has a high industrial component. The graph also
shows that the calculation tends to overestimate the estro-
genicity. However, due to the measurement uncertainties
involved, this should by no means be over interpreted.
Fish exposure experiments
Most exposed individuals (>95%) were male except for
the WWTP Rontal experiment (51% male). Individual
VTG data from before the experiment was not available
for the Rontal exposure due to loss of tags. The fish were
exposed for a period of two weeks for all treatment exper-
iments, except for a three-week exposure at Surental, and
one of the two Glatt experiments (Table 2). The three ex-
posures in Switzerland were done in the fall (first week of
September to first week of November), while the French
exposures were undertaken in spring (end of April and end
of May).
Survival of the fish in the experiments conducted at the
WWTPs Glatt and France1 were high (>95%). Rainbow
trout used for the exposure at the Rontal WWTP had a
fungal skin infection (Saprolegnia) and had higher mor-
tality in all treatments. Fish survival during the Surental
effluent treatment was low (33%) for unknown reasons,
while the observed increased mortality in the river-water
treatment was caused by an accidental oversaturation with
oxygen. The high mortality found for the effluent-treated
trout at the WWTP France2 was caused by very high am-
monia concentrations of up to 26 mg L–1 on exposure day
7. This concentration was much higher than the reported
acute toxic concentration of 200 µg L-1, for non-ionized
ammonia (NH3) [46, 47]. To avoid total loss in the efflu-
ent and mixed water treatment groups, the treatments
were interrupted for 12 h and run with river water to allow
the trout to recover from the ammonia peak.
HSI (hepatosomatic index) and GSI (gonadosomatic
index) were calculated for each single fish. However, in
none of the experiments were changes in HSI and GSI
significant between treatment and control.
In vitro versus VTG concentrations in blood plasma
Significant estrogenic activities were measured in vitro
with the YES in all WWTP effluents analyzed. The mea-
sured values obtained with the YES correlated well with
the estradiol equivalents calculated based on the chemical
data, and most importantly did not give false negative re-
sults (Fig. 1). This clearly supports the idea of using YES
as an in vitro tool for a first screening of environmental
samples. YES is an easy, relatively fast, and robust in vitro
assay that has recently been shown to give results similar
to those of other in vitro tests, based either on the use of
primary fish hepatocytes or fish cell lines [33]. Potential
hazards can thus be determined in a sensitive way and rel-
atively fast. In the case of a positive in vitro response, a
further level of biological effect integration can be envis-
aged by using in vivo effect analysis, which also takes
into account toxicokinetic and toxicodynamic effects. The
importance of this validation step has recently been exam-
ined by Legler et al. [48]. They showed that effects seen
in vitro do not necessarily mean observable in vivo ef-
fects.
In the work presented here we observed a clearly in-
duced vitellogenesis in male rainbow trout exposed to
sewage effluents from the WWTPs Glatt and Rontal. This
is visualized by an increased number of fish having higher
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Fig. 1 Estrogenicity deter-
mined with the yeast estrogen
screen (YES) versus calculated
estradiol equivalents, based on
chemical data (E2-EQ calcu-
lated)
concentrations of VTG in Fig. 2. These results indicate es-
trogenic activity in both effluents. Interestingly, no signif-
icant increase of VTG blood plasma concentrations were
found at the Surental, France1, and France2 sites (see Fig. 2).
We do not understand the different responses in vitro ver-
sus in vivo. The hERα is used in YES, while rtERα is pre-
sent in the in vivo test. Differential binding for the two es-
trogen receptors for steroid hormones and for xenoestro-
gens has been described controversially [41, 49, 50, 51].
This differential binding can, however, not explain why
no in vivo responses have been observed. Owing to the
annual cycle of reproductive hormones in both females
and males [52] and as a consequence the inducibility of
VTG, the seasonally different exposure schemes (autumn in
exposures in Switzerland; spring in exposures in France),
could partly have contributed to the different response
patterns. The negative in vivo response in estrogenic ef-
fluents could be due either to the presence of anti-estro-
gens in the effluents of these treatment plants, or hepato-
toxicity-induced reduction of VTG synthesis, or diet. How-
ever, anti-estrogenicity could have been detected with the
YES assay. The observed reduction of VTG levels during
exposure (Surental, France1, and France2) is most likely
caused by estrogenic compounds in the pellets used for
feeding at the hatchery before the experiment. Indeed, es-
trogenicity was measured with the YES (0.12 ng g–1 dry
weight) in an aqueous extract of the feeding pellets, which
very possibly accounts for the elevated VTG levels at the
onset of the experiments. No steroid hormones were de-
tected either in aqueous, or hexane extracts of the feeding
pellets (A.C. Vögeli, unpublished results). We have no ex-
planation for the different in vivo response in the various
effluents, but the results clearly illustrate the difficulty of
predicting a propagation of effects onto a higher level of
biological organization. A positive effect seen in vitro should
hence clearly be defined as a potential hazard, rather than
a proof for a biological effect in higher organisms.
Conclusion
In this work we have assessed the estrogenic activity of
wastewater treatment plant effluents and combined chem-
ical analysis and biological effect analysis, in vitro as well
as in vivo. We showed that natural and synthetic steroid
hormones are the major contributors to estrogenicity in
the effluents tested. We can, however, not exclude that xe-
noestrogens might have a significant contribution in other
effluents. The calculated (based on chemical analysis and
using the principle of concentration additivity) and mea-
sured (YES) estrogenicity correlated well (R2=0.6). No
false negative results were obtained in vitro thereby sup-
porting the use of YES as an in vitro tool for first screen-
ing purposes. Effects seen in vitro must not necessarily
mean that in vivo effects will occur. The fact that three out
of five estrogenic effluents did not induce vitellogenesis
clearly shows that prediction of effects in vivo from in vitro
data is and will be extremely difficult. It also shows that
we are still very far away from understanding and predict-
ing endocrine disruption, particularly if the effects of com-
plex environmental mixtures are being studied.
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